Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ)
Makes vaccines and biological medicines for diseases like COVID-19 and tuberculosis in China.
12.63+0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-47.0%
The outlook
Analysts lean bullish on Zhifei Biological with a buy consensus and an average price target around 68% above the current level. However, the stock is trading well below both its 50- and 200-day moving averages, sitting near the lower end of its 52-week range, signaling recent weakness. The mismatch between analyst optimism and near-term price action leaves the outlook mixed.
What’s behind the score
Analyst consensusBuy — 2.3 avg of 3 analysts
Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Price targetAvg target +68% vs current price
Analyst price target
~12-month · 3 analysts21.17average target+67.6% vs now
Now 12.63
Low 14.10High 29.40
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$30.23B
52-wk high
26.00
52-wk low
11.07
50-day avg
12.63
200-day avg
16.56
Trailing P/E
—
Similar stocks
300015.SZAier Eye Hospital Group Co., Ltd.$8.87+2.90%000661.SZChangchun High-Tech Industry (Group) Co., Ltd.$81.15+1.97%300142.SZWalvax Biotechnology Co., Ltd.$12.19+1.58%300760.SZShenzhen Mindray Bio-Medical Electronics Co., Ltd.$154.88+2.88%300347.SZHangzhou Tigermed Consulting Co., Ltd$50.78+5.66%